ProductNum | picture | CAS No. | Name and description | Formula | Quick order |
---|---|---|---|---|---|
CL2509 |
|
1013920-15-4 |
Vorolanib (X-82,CM082) 98+% |
C23H26FN5O3 | |
CLA1339 |
|
1350624-75-7 |
Margetuximab (Anti-ERBB2 / HER2 / CD340) 95+% |
— | |
CLA1267 |
|
1024603-92-6 |
Icrucumab (Anti-VEGFR1 / FLT1) 95+% |
— | |
CLA1179 |
|
934216-54-3 |
Alacizumab (Anti-VEGFR2 / KDR / CD309) 95+% |
— | |
CL2214 |
|
215543-92-3 |
(Z)-3-(4-methyl-2-((2-oxoindolin-3-ylidene)methyl)-1H-pyrrol-3-yl)propanoic acid. 98+% |
C17H16N2O3 | |
CLA1033 |
|
1018448-65-1 |
Ado-trastuzumab Emtansine (TDM-1) 95+% |
— | |
CL1033 |
|
808118-40-3 |
Roxadustat (FG-4592) 98+% |
C19H16N2O5 | |
CLA1025 |
|
380610-27-5 |
Pertuzumab; 2C4 98+% |
— | |
CLA1018 |
|
947687-13-0 |
Ramucirumab; LY3009806; IMC-1121B 98+% |
— | |
CLA1008 |
|
216974-75-3 |
Bevacizumab (anti-VEGF) ; rhuMab VEGF 95+% |
— | |
CL2190 |
|
698387-09-6 |
Neratinib (HKI-272) 98+% |
C30H29ClN6O3 | |